BROOKE SEAGO: Open Payments
NPI 1962435768 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,008 in 101 payments from 20 companies in 2025. Trend: 2023 $1,683 · 2024 $1,199 · 2025 $2,008
Food & beverage: $2,008
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $235 |
| GlaxoSmithKline, LLC. | 14 | $208 |
| Insmed, Inc. | 8 | $191 |
| HARMONY BIOSCIENCES LLC | 6 | $171 |
| Merck Sharp & Dohme LLC | 7 | $143 |
| Vifor Pharma, Inc. | 11 | $139 |
| United Therapeutics Corporation | 5 | $131 |
| Verona Pharma, Inc. | 5 | $110 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $100 |
| Viatris Specialty LLC | 3 | $88 |
Products named: Arikayce, WAKIX, FASENRA, ZERBAXA, DUPIXENT, Zemaira, Tyvaso, NUCALA.
Industry payments across AR — which companies pay providers there.
